Estimated Parasite Density Distributions Derived From 1000 Imputed Data Sets
Predicted Log-Normal Distributions . | Plasmodium falciparum . | Plasmodium vivaxa . | |||||||
---|---|---|---|---|---|---|---|---|---|
. | . | . | Scenario A . | Scenario B . | |||||
Mean . | Range . | IQR . | Mean . | Range . | IQR . | Mean . | Range . | IQR . | |
PPF = 0.1214 for all parasite densities (30–30 000 000 parasites/mL) | |||||||||
Mean | 2.86 | 1.97–3.31 | 2.75–2.97 | 3.34 | 3.31–3.38 | 3.33–3.35 | 3.25 | 3.16–3.33 | 3.23–3.27 |
SD | 2.16 | 1.90–2.66 | 2.09–2.22 | 1.60 | 1.57–1.62 | 1.60–1.60 | 1.64 | 1.58–1.71 | 1.63–1.66 |
Percentage below LLOQb | 25.6 | 16.3–42.2 | 23.3–27.8 | 11.8 | 11.0–12.6 | 11.7–12.0 | 13.6 | 11.7–15.7 | 13.2–14.0 |
Percentage above ULOQc | 1.6 | 1.1–2.1 | 1.5–1.7 | 0.48 | 0.45–0.51 | 0.48–0.49 | 0.50 | 0.42–0.59 | 0.48–0.52 |
PPF = 0.1534 for parasite density of 30–999 parasites/mL; 0.1124 for parasite density 1000–30 000 000 parasites/mL | |||||||||
Mean | 2.64 | 1.92–3.27 | 2.49–2.79 | 3.35 | 3.31–3.39 | 3.35–3.36 | 3.26 | 3.15–3.36 | 3.24–3.28 |
SD | 2.26 | 1.95–2.65 | 2.17–2.33 | 1.59 | 1.57–1.61 | 1.59–1.60 | 1.63 | 1.56–1.72 | 1.62–1.65 |
Percentage below LLOQb | 29.8 | 17.9–42.9 | 26.8–32.7 | 11.5 | 10.9–12.4 | 11.4–11.7 | 13.3 | 11.0–16.1 | 12.9–13.8 |
Percentage above ULOQc | 1.6 | 1.1–2.2 | 1.5–1.7 | 0.48 | 0.46–0.51 | 0.48–0.49 | 0.50 | 0.42–0.59 | 0.48–0.52 |
Predicted Log-Normal Distributions . | Plasmodium falciparum . | Plasmodium vivaxa . | |||||||
---|---|---|---|---|---|---|---|---|---|
. | . | . | Scenario A . | Scenario B . | |||||
Mean . | Range . | IQR . | Mean . | Range . | IQR . | Mean . | Range . | IQR . | |
PPF = 0.1214 for all parasite densities (30–30 000 000 parasites/mL) | |||||||||
Mean | 2.86 | 1.97–3.31 | 2.75–2.97 | 3.34 | 3.31–3.38 | 3.33–3.35 | 3.25 | 3.16–3.33 | 3.23–3.27 |
SD | 2.16 | 1.90–2.66 | 2.09–2.22 | 1.60 | 1.57–1.62 | 1.60–1.60 | 1.64 | 1.58–1.71 | 1.63–1.66 |
Percentage below LLOQb | 25.6 | 16.3–42.2 | 23.3–27.8 | 11.8 | 11.0–12.6 | 11.7–12.0 | 13.6 | 11.7–15.7 | 13.2–14.0 |
Percentage above ULOQc | 1.6 | 1.1–2.1 | 1.5–1.7 | 0.48 | 0.45–0.51 | 0.48–0.49 | 0.50 | 0.42–0.59 | 0.48–0.52 |
PPF = 0.1534 for parasite density of 30–999 parasites/mL; 0.1124 for parasite density 1000–30 000 000 parasites/mL | |||||||||
Mean | 2.64 | 1.92–3.27 | 2.49–2.79 | 3.35 | 3.31–3.39 | 3.35–3.36 | 3.26 | 3.15–3.36 | 3.24–3.28 |
SD | 2.26 | 1.95–2.65 | 2.17–2.33 | 1.59 | 1.57–1.61 | 1.59–1.60 | 1.63 | 1.56–1.72 | 1.62–1.65 |
Percentage below LLOQb | 29.8 | 17.9–42.9 | 26.8–32.7 | 11.5 | 10.9–12.4 | 11.4–11.7 | 13.3 | 11.0–16.1 | 12.9–13.8 |
Percentage above ULOQc | 1.6 | 1.1–2.2 | 1.5–1.7 | 0.48 | 0.46–0.51 | 0.48–0.49 | 0.50 | 0.42–0.59 | 0.48–0.52 |
Abbreviations: IQR, interquartile range; PPF, probability of infection being due to P. falciparum; SD, standard deviation.
a Scenario A describes asynchronous infections. Scenario B describes synchronous infections (SD, 4 hours).
b The lower limit of quantification (LLOQ) was defined as <30 parasites/mL.
c The upper limit of quantification (ULOQ) was defined as >30 000 000 parasites/mL.
Estimated Parasite Density Distributions Derived From 1000 Imputed Data Sets
Predicted Log-Normal Distributions . | Plasmodium falciparum . | Plasmodium vivaxa . | |||||||
---|---|---|---|---|---|---|---|---|---|
. | . | . | Scenario A . | Scenario B . | |||||
Mean . | Range . | IQR . | Mean . | Range . | IQR . | Mean . | Range . | IQR . | |
PPF = 0.1214 for all parasite densities (30–30 000 000 parasites/mL) | |||||||||
Mean | 2.86 | 1.97–3.31 | 2.75–2.97 | 3.34 | 3.31–3.38 | 3.33–3.35 | 3.25 | 3.16–3.33 | 3.23–3.27 |
SD | 2.16 | 1.90–2.66 | 2.09–2.22 | 1.60 | 1.57–1.62 | 1.60–1.60 | 1.64 | 1.58–1.71 | 1.63–1.66 |
Percentage below LLOQb | 25.6 | 16.3–42.2 | 23.3–27.8 | 11.8 | 11.0–12.6 | 11.7–12.0 | 13.6 | 11.7–15.7 | 13.2–14.0 |
Percentage above ULOQc | 1.6 | 1.1–2.1 | 1.5–1.7 | 0.48 | 0.45–0.51 | 0.48–0.49 | 0.50 | 0.42–0.59 | 0.48–0.52 |
PPF = 0.1534 for parasite density of 30–999 parasites/mL; 0.1124 for parasite density 1000–30 000 000 parasites/mL | |||||||||
Mean | 2.64 | 1.92–3.27 | 2.49–2.79 | 3.35 | 3.31–3.39 | 3.35–3.36 | 3.26 | 3.15–3.36 | 3.24–3.28 |
SD | 2.26 | 1.95–2.65 | 2.17–2.33 | 1.59 | 1.57–1.61 | 1.59–1.60 | 1.63 | 1.56–1.72 | 1.62–1.65 |
Percentage below LLOQb | 29.8 | 17.9–42.9 | 26.8–32.7 | 11.5 | 10.9–12.4 | 11.4–11.7 | 13.3 | 11.0–16.1 | 12.9–13.8 |
Percentage above ULOQc | 1.6 | 1.1–2.2 | 1.5–1.7 | 0.48 | 0.46–0.51 | 0.48–0.49 | 0.50 | 0.42–0.59 | 0.48–0.52 |
Predicted Log-Normal Distributions . | Plasmodium falciparum . | Plasmodium vivaxa . | |||||||
---|---|---|---|---|---|---|---|---|---|
. | . | . | Scenario A . | Scenario B . | |||||
Mean . | Range . | IQR . | Mean . | Range . | IQR . | Mean . | Range . | IQR . | |
PPF = 0.1214 for all parasite densities (30–30 000 000 parasites/mL) | |||||||||
Mean | 2.86 | 1.97–3.31 | 2.75–2.97 | 3.34 | 3.31–3.38 | 3.33–3.35 | 3.25 | 3.16–3.33 | 3.23–3.27 |
SD | 2.16 | 1.90–2.66 | 2.09–2.22 | 1.60 | 1.57–1.62 | 1.60–1.60 | 1.64 | 1.58–1.71 | 1.63–1.66 |
Percentage below LLOQb | 25.6 | 16.3–42.2 | 23.3–27.8 | 11.8 | 11.0–12.6 | 11.7–12.0 | 13.6 | 11.7–15.7 | 13.2–14.0 |
Percentage above ULOQc | 1.6 | 1.1–2.1 | 1.5–1.7 | 0.48 | 0.45–0.51 | 0.48–0.49 | 0.50 | 0.42–0.59 | 0.48–0.52 |
PPF = 0.1534 for parasite density of 30–999 parasites/mL; 0.1124 for parasite density 1000–30 000 000 parasites/mL | |||||||||
Mean | 2.64 | 1.92–3.27 | 2.49–2.79 | 3.35 | 3.31–3.39 | 3.35–3.36 | 3.26 | 3.15–3.36 | 3.24–3.28 |
SD | 2.26 | 1.95–2.65 | 2.17–2.33 | 1.59 | 1.57–1.61 | 1.59–1.60 | 1.63 | 1.56–1.72 | 1.62–1.65 |
Percentage below LLOQb | 29.8 | 17.9–42.9 | 26.8–32.7 | 11.5 | 10.9–12.4 | 11.4–11.7 | 13.3 | 11.0–16.1 | 12.9–13.8 |
Percentage above ULOQc | 1.6 | 1.1–2.2 | 1.5–1.7 | 0.48 | 0.46–0.51 | 0.48–0.49 | 0.50 | 0.42–0.59 | 0.48–0.52 |
Abbreviations: IQR, interquartile range; PPF, probability of infection being due to P. falciparum; SD, standard deviation.
a Scenario A describes asynchronous infections. Scenario B describes synchronous infections (SD, 4 hours).
b The lower limit of quantification (LLOQ) was defined as <30 parasites/mL.
c The upper limit of quantification (ULOQ) was defined as >30 000 000 parasites/mL.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.